Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Lieuwe de Haan

51-100 of 325 results

Adult attachment and psychotic phenomenology in clinical and non‐clinical samples: A systematic review

scientific article published on 02 July 2013

Attitudes of patients toward the first psychotic episode and the start of treatment.

scientific article published in January 2002

Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness

scientific article

Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls

scientific article published in March 2010

Early interventions in risk groups for schizophrenia: what are we waiting for?

scientific article

The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication.

scientific article

Proton magnetic resonance spectroscopy in 22q11 deletion syndrome

scientific article

Transition to first episode psychosis in ultra high risk populations: does baseline functioning hold the key?

scientific article published on 19 November 2012

Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study

scientific article

Can quantitative EEG measures predict clinical outcome in subjects at Clinical High Risk for psychosis? A prospective multicenter study

scientific article published on 6 February 2014

The Effect of Motivational Interviewing on Medication Adherence and Hospitalization Rates in Nonadherent Patients with Multi-Episode Schizophrenia

scientific article published on September 26, 2013

Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls

scientific article published on 25 November 2013

Obsessive-compulsive symptoms and positive, negative, and depressive symptoms in patients with recent-onset schizophrenic disorders

scientific article published in August 2005

Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years.

scientific article published on 25 April 2018

Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study

scientific article published in October 2011

Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders

scientific article published in December 2004

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

scientific article published on 16 August 2015

Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis

scientific article published on January 1, 2012

Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets

scientific article

Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity?

scientific article published in January 2009

Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis

scientific article published on May 14, 2012

History of trauma and the association with baseline symptoms in an Ultra-High Risk for psychosis cohort

scientific article

Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis

scientific article published in April 2008

Subjective Well-Being in Schizophrenia as Measured with the Subjective Well-Being Under Neuroleptic Treatment Scale: A Review

scientific article published on March 1, 2011

Subjective experiences during dopamine depletion

scientific article published in September 2005

Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial

scientific article published in June 2008

Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale in schizophrenia patients

scientific article published on 01 January 2006

Cognitive impairment in late life schizophrenia and bipolar I disorder

scientific article published on March 12, 2012

AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures

scientific article published on 19 February 2008

Presence of obsessive compulsive symptoms in first‐episode schizophrenia or related disorders is associated with subjective well‐being and quality of life

scientific article published on July 3, 2012

Semantic fluency deficits and reduced grey matter before transition to psychosis: A voxelwise correlational analysis

scientific article published on 09 August 2011

The Relationship Between Clinical and Personal Recovery in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis.

scientific article published on 14 July 2017

Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders.

scientific article published on May 2015

Modelling the treated course of schizophrenia: development of a discrete event simulation model

scientific article published on 01 January 2005

Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study

scientific article published on January 23, 2013

Feasibility of mindfulness-based therapy in patients recovering from a first psychotic episode: a pilot study

scientific article published on 9 March 2012

Prevalence of psychotic disorders in patients with obsessive-compulsive disorder

scientific article published in August 2009

Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study

scientific article published on 24 August 2013

Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis

scientific article published on 12 February 2014

Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis

scientific article

The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder

scientific article published on 13 June 2019

Dissociable morphometric profiles of the affective and cognitive dimensions of alexithymia

scientific article

Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia

scientific article

Subjective effects of cannabis before the first psychotic episode

scientific article published in December 2009

Theory of mind, insecure attachment and paranoia in adolescents with early psychosis and healthy controls

scientific article

Alexithymia influences brain activation during emotion perception but not regulation

scientific article

Suicide Risk in Placebo vs Active Treatment in Placebo-Controlled Trials for Schizophrenia

scientific article published on 01 April 2003

Dopaminergic modulation of the human reward system: a placebo-controlled dopamine depletion fMRI study

scientific article

Obsessive–Compulsive Symptoms in First Episode Psychosis and in Subjects at Ultra High Risk for Developing Psychosis; Onset and Relationship to Psychotic Symptoms

scientific article published on November 18, 2010

Social Functioning Among Older Community-Dwelling Patients With Schizophrenia: A Review

scientific article published on October 1, 2010